Learn

Gain practical, whole-of-practice strategies to identify, assess, and manage metabolic dysfunction-associated fatty liver disease (MAFLD) in this focused 90-minute masterclass. Now the most common liver condition in Australia, MAFLD is closely linked to obesity, type 2 diabetes, cardiovascular disease, and CKD. Led by national experts in hepatology and general practice, this session will equip you with the tools to detect at-risk patients, apply the FIB-4 index at the point of care, and embed MAFLD workflows into chronic disease management.

Details

Delivery method: Online via Zoom  

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.